Data / Form D filings / NeuroDex Inc
NeuroDex Inc: Form D filings
NeuroDex Inc, a biotechnology company in Natick, MA, filed 3 Form D notices with the SEC between 2020 and 2023. The latest, on May 2, 2023, reports $60,000 sold of a $750,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 27 STRATHMORE RD., Natick, MA, 01760
- Phone
- (607) 937-4811
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1801963
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 2, 2023 | New notice | $750,000 | $60,000 | $690,000 | 1 | Mar 14, 2023 | sec.gov |
| Aug 30, 2022 | New notice | $2,000,000 | $799,989 | $1,200,011 | 3 | Aug 16, 2022 | sec.gov |
| Feb 3, 2020 | New notice | $500,000 | $500,000 | 1 | Jan 24, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gary Magnant | Director | |
| Oded Biran | Executive Officer, Director | |
| Raphael Nir | Director | |
| Erez Eitan | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 1, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NeuroDex Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.